In The Lancet Global Health, Stéphane Verguet and colleagues report a modelling study of the effects of expanding TB services on averting catastrophic costs to TB-affected households in India and South Africa. They assessed three different scenarios of TB control: improved treatment of drug-sensitiveTB; improved treatment of multidrug-resistant TB; and expanded access to services (all individuals who seek care being screened for TB symptoms; South Africa only). The outcomes were compared with a base case, which assumed that coverage and treatment success rates at start of the study would be maintained at a constant from 2016 to 2035. They used extended cost-effectiveness analysis as a complement to their model to estimate the differential effects of the scenarios across socioeconomic quintiles.
Read the full study, Catastrophic costs potentially averted by tuberculosis control in India and South Africa: a modelling study, here.
Read an accompanying comment, Mitigating the financial effects of tuberculosis requires more than expansion of services, here.